Showing results (71-80 of 692) with videos related to
Sort By:
Pageof 70
Neuropharmacology|March 1, 1994
The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptorsS J Peroutka, T A HowellCancer Treatment Reports|May 1, 1986
Neurotransmitter receptor binding studies predict antiemetic efficacy and side effectsP J Ison, S J PeroutkaEpilepsia|July 1, 1990
Neurotransmitter receptors in adult tottering (tg/tg) miceA E Dusser, S J PeroutkaHeadache|July 1, 1989
Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175)B G McCarthy, S J PeroutkaPsychopharmacology|January 1, 1989
Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortexP A Pierce, S J PeroutkaBiochemical Pharmacology|June 15, 1986
Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT)J R Schlegel, S J PeroutkaBrain Research|December 8, 1987
Identification of 5-hydroxytryptamine binding site subtypes in rat spinal cordJ C Huang, S J PeroutkaNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1988
Subjective effects of 3,4-methylenedioxymethamphetamine in recreational usersS J Peroutka, H Newman, H HarrisNeurology|July 1, 1997
Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI allelesS J Peroutka, T Wilhoit, K JonesHeadache|July 1, 1993
Wolff Award presentation 1993. Anti-migraine drug interactions with cloned human 5-hydroxytryptamine1 receptor subtypesS J Peroutka, S Havlik, D OksenbergPageof 70